The median length of stay was 13 days (range: 1–92 days) with a decreasing trend over the observational period.
← all excerpts
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency.
1
—
—